Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
- Colomer-Carbonell, A.
- Sanabria-Mazo, J.P.
- Hernández-Negrín, H.
- Borràs, X.
- Suso-Ribera, C.
- Garciá-Palacios, A.
- Muchart, J.
- Munuera, J.
- D'Amico, F.
- Maes, M.
- Younger, J.W.
- Feliu-Soler, A.
- Rozadilla-Sacanell, A.
- Luciano, J.V.
Revue:
BMJ Open
ISSN: 2044-6055
Année de publication: 2022
Volumen: 12
Número: 1
Type: Article